HIV researchers edge closer to a cure
British man with HIV hoping to be cured of the disease after unprecedented collaboration between universities

A free daily digest of the biggest news stories of the day - and the best features from our website
Thank you for signing up to TheWeek. You will receive a verification email shortly.
There was a problem. Please refresh the page and try again.
How modified HIV cells are being used to treat cancer
12 November 2014
A man with an aggressive form of cancer has gone into remission after receiving pioneering treatment involving the use of modified HIV cells. Marshall Jensen from Utah was diagnosed with leukaemia in early 2012 and had been receiving the gene therapy for the past few months.
Last year, seven-year old Emily Whitehead was given the same treatment and remains cancer free. But how does the therapy work and why are some experts still concerned about its use?
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
What is the treatment and how does it work?
Dr Carl June, a highly respected scientist in the field of cancer, HIV and immunology, and his team have been developing the pioneering the treatment for more than two decades at a research hospital in Pennsylvania.
The treatment, which costs roughly $20,000 per patient, essentially trains the immune system to recognise and kill tumour cells. Scientists extract healthy t-cells, a type of white blood cell that fights infection, and reprogramme them with modified version of the HIV virus. "It's a disabled virus," June explained. "But it retains the one essential feature of HIV, which is the ability to insert new genes into cells."
This new gene then "makes the cells go after cancer cells and then we put those cells back in the patient", explains Dr Stephan Grupp, the doctor who treated Whitehead. These cells then grow and multiply, creating an "an army of killer cells" that fight the disease, according to Cancer Research UK.
How effective is it?
Nine out of the 12 cancer patients who have received the treatment are in either full or partial remission, according to the Idaho-based KSL news who reported on Jensen's remission. However, some of those patients went on to have different treatment, so it is unclear whether the gene therapy was solely responsible for their recovery.
"We make it clear when we talk to a family that it may not work", says Dr Gupp, and Cancer Research agrees that this is an important caveat. "It's clear that it doesn't work for everyone", it said.
What are the other downsides?
The treatment has severe side effects. Several patients suffered what is known as a "cytokine storm", a dangerous and potentially fatal reaction by the immune system which causes breathing difficulties and can also cause significant damage to organs.
Experts also stress that the treatment is still highly experimental and trials are still underway to establish its efficacy and safety. "There is a lot more work to be done to find out how best to use this new technology," said Cancer Research.
What next?
Scientists are working to extend its use beyond leukaemia, with Dr June planning to begin trials soon for pancreatic cancer.
"It's still early days for these exciting new approaches and there are many hurdles to jump," said Cancer Research, "but we're looking forward to the day when they can be used to treat patients on a wider scale."
Continue reading for free
We hope you're enjoying The Week's refreshingly open-minded journalism.
Subscribed to The Week? Register your account with the same email as your subscription.
Sign up to our 10 Things You Need to Know Today newsletter
A free daily digest of the biggest news stories of the day - and the best features from our website
-
Why the Roman Empire is suddenly everywhere online
The Explainer It fell more than 1,500 years ago — so why is it dominating social media?
By Justin Klawans Published
-
How climate change is going to change the insurance industry
The Explainer Some regions will soon be 'uninsurable'
By Devika Rao Published
-
TV to watch in October, from 'Loki' to 'The Fall of the House of Usher'
The Explainer Celebrate spooky season with some eerie streaming shows
By Brendan Morrow Published
-
Good health news: seven surprising medical discoveries made in 2023
In Depth A fingerprint test for cancer, a menopause patch and the shocking impacts of body odour are just a few of the developments made this year
By The Week Staff Published
-
Five good-news cancer breakthroughs in 2023
In Depth Cancer-sniffing ants, ‘Bond villain’ DNA, and vaccine trials are just a few exciting developments in cancer research this year
By The Week Staff Published
-
mRNA technology and a vaccine for cancer
feature Cure is ‘in our grasp’ say the scientists behind the BioNTech Covid-19 jab
By The Week Staff Published
-
Do vegans live longer?
feature Plant-based lifestyles can drastically lower rates of some serious diseases
By Chas Newkey-Burden Published
-
Sanofi/GSK/Haleon: cancer fears prove hard to stomach
Business Briefing Shares of GlaxoSmithKline, Sanofi and the new GSK spin-off, Haleon, all fell sharply last week
By The Week Staff Published
-
The Week Unwrapped: Immunotherapy, unions and a house revival
podcast Can our immune systems help us fight cancer? Have unions finally cracked the tech sector? And is 90s house music making a comeback?
By The Week Staff Published
-
The pros and cons of drinking coffee
Pros and Cons Studies have shown drinking it in moderation can reduce risk of certain diseases – but it should be avoided during pregnancy
By The Week Staff Published
-
Deborah James: tireless cancer campaigner dies aged 40
Why Everyone’s Talking About The bowel cancer campaigner raised millions for cancer research charities
By The Week Staff Last updated